VIP and hepatocellular carcinoma: To investigate the underlying mechanism by which VIP inhibits HCC progression, we performed RNA-seq analyses of Huh-7 cells with VIRP1 overexpression and VIP treatment (VIP/VIPR1 group) and Huh-7 cells with vector expression and without VIP treatment (control group) (Fig. S4A).